Champions Oncology, Inc. is leading the way in personalized cancer care with its innovative Tumorgraft Technology Platform. This platform involves implanting human tumors in immune-deficient mice and has revolutionized the development and use of oncology drugs in the United States. By utilizing its cutting-edge technology, Champions Oncology provides Translational Oncology Solutions to assist pharmaceutical and biotechnology companies in their drug development processes. The company also offers Lumin Bioinformatics, a software platform and data tool with comprehensive information derived from research services and clinical studies that is available on an annual subscriptions basis. Through online marketing, word of mouth, and sales force efforts, Champions Oncology markets its products to patients and physicians across the country. The company was founded in 1985 as Champions Biotechnology, Inc. before rebranding as Champions Oncology, Inc. in April 2011. With headquarters in Hackensack, New Jersey, Champions Oncology is dedicated to improving cancer care through cutting-edge technology and innovative solutions.
Champions Oncology's ticker is CSBR
The company's shares trade on the NASDAQ stock exchange
They are based in Hackensack, New Jersey
There are 51-200 employees working at Champions Oncology
It is championsoncology.com
Champions Oncology is in the Healthcare sector
Champions Oncology is in the Biotechnology industry
The following five companies are Champions Oncology's industry peers: